XML 50 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 30, 2020
Feb. 28, 2019
Jun. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Oscine Corp                
Business Acquisition [Line Items]                
Business acquisition, consideration transferred $ 8,500,000              
Oscine Corp | Stock Purchase Agreement                
Business Acquisition [Line Items]                
Business acquisition, percentage of voting interests acquired 100.00%     100.00%        
Business acquisition, consideration transferred $ 8,500,000     $ 8,500,000        
Business acquisition, consideration transferred, cash 7,600,000              
Business acquisition, consideration holdback amount 900,000              
Oscine Corp | Stock Purchase Agreement | Maximum                
Business Acquisition [Line Items]                
Future milestone payments upon achievement of certain development and commercial milestones $ 225,800,000     $ 225,800,000        
Cobalt Biomedicine, Inc | Acquisition Agreement                
Business Acquisition [Line Items]                
Business acquisition, percentage of voting interests acquired   100.00%            
Maximum success payment upon achievement of certain pre-specified development milestones   $ 500,000,000.0            
Maximum period for success payment to achieve   20 years            
Cobalt Biomedicine, Inc | Acquisition Agreement | Research and Development                
Business Acquisition [Line Items]                
Estimated fair value of success payment liability     $ 89,800,000     $ 89,800,000   $ 64,700,000
Estimated fair value of contingent consideration     140,500,000     140,500,000   $ 121,900,000
(Gain) expense in connection with change in estimated fair value of success payment     (66,600,000)   $ 33,500,000 25,100,000 $ 33,900,000  
Expense in connection with change in estimated fair value of contingent consideration     $ 7,200,000   $ 14,000,000.0 $ 18,600,000 $ 14,300,000  
Cobalt Biomedicine, Inc | Acquisition Agreement | Market Capitalization Equal to or Exceeds $8.1 billion                
Business Acquisition [Line Items]                
Cobalt success payment   $ 500,000,000.0            
Cobalt Biomedicine, Inc | Acquisition Agreement | Minimum [Member]                
Business Acquisition [Line Items]                
Threshold market capitalization   $ 8,100,000,000